Step 1: Understanding pFox inhibitors. Partial Fatty acid oxidation (pFox) inhibitors, such as Trimetazidine, work by shifting myocardial energy metabolism from fatty acid oxidation to glucose oxidation. This is more oxygen-efficient and helps improve cardiac efficiency, especially in conditions like ischemic heart disease.
Step 2: Explanation of Trimetazidine. Trimetazidine is the prototype pFox inhibitor. It selectively inhibits long-chain 3-ketoacyl-CoA thiolase (an enzyme involved in fatty acid oxidation), thereby enhancing glucose oxidation and reducing myocardial oxygen demand.
Step 3: Comparison with other options. - Option \( (B) \): Atosiban is an oxytocin receptor antagonist used in preterm labor, not a pFox inhibitor.
- Option \( (C) \): Verapamil is a calcium channel blocker used for angina and arrhythmias, not a pFox inhibitor.
- Option \( (D) \): Nicardipine is also a calcium channel blocker and not related to fatty acid oxidation.
Conclusion: Trimetazidine is the correct answer as a pFox inhibitor.
List I | List II | ||
|---|---|---|---|
| A | \(\Omega^{-1}\) | I | Specific conductance |
| B | \(∧\) | II | Electrical conductance |
| C | k | III | Specific resistance |
| D | \(\rho\) | IV | Equivalent conductance |
List I | List II | ||
|---|---|---|---|
| A | Constant heat (q = 0) | I | Isothermal |
| B | Reversible process at constant temperature (dT = 0) | II | Isometric |
| C | Constant volume (dV = 0) | III | Adiabatic |
| D | Constant pressure (dP = 0) | IV | Isobar |